Noble International is working with Pharma and Specialty Pharmacy to fix the problem. The report, “The Current Paradigm for Biologic Initiation: A Mixed-Methods Exploration of Practices, Unmet Needs, and Innovation Opportunities in Self-Injection Training,” chronicles a study meant to examine the current injection initiation experiences of patients. Here, significant gaps in training and support were…
Noble Leads with its User-Centered Design Strategy
By Tim McLeroy, Executive Director of Marketing and Patient Services, Noble International At Noble, the patient journey drives everything we do. Our patient-centered approach pushes us to fully understand and characterize patient needs, providing data and experiences that help us ease the burden and anxiety of self-administered treatments. While drug delivery devices are well designed…
Noble expands its services for its clients into Human Factors
Human Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug therapies By Tim McLeroy, Executive Director of Marketing & Patient Services The global market for medical devices is approximately $436 billion, bolstered by an aging population, according to data from hfMEDIC, the University of Utah-led […]